<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918917</url>
  </required_header>
  <id_info>
    <org_study_id>2011/329</org_study_id>
    <secondary_id>2011/329</secondary_id>
    <nct_id>NCT01918917</nct_id>
  </id_info>
  <brief_title>Adding Intra-articular Dexmedetomidine to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery</brief_title>
  <official_title>Phase 4 Study of Intra-articular Dexmedetomidine Adding to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to search efficacy of intra-articular dexmedetomidine addition to
      levobupivacaine for postoperative analgesia in arthroscopic knee surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients between 18-65 years and with American Society of Anesthesiologists' (ASA) Physical
      Status class I-II, who were scheduled for arthroscopic knee surgery, were enrolled in a
      randomised comparative clinical trial. Blinding or masking began in the preoperative holding
      unit. Exclusion criteria were psychiatric illness, younger than 18 yo, who has analgesic
      treatment before the surgery and known hypersensitivity to relevant drugs. All patients
      received a standard anaesthetic protocol; ECG, heart rate, non-invasive blood pressure,
      oxygen saturation and temperature were monitored. After preoxygenation, general anaesthesia
      was induced with sodium pentothal 4 to 7 mg/kg, 1 mcg/kg fentanyl and neuromuscular block was
      achieved with rocuronium 0.5 mg/kg and trachea was intubated. Anesthesia was maintained with
      desflurane 6% and 50% oxygen in the medical air.

      Randomised patients were achieved dexmedetomidine and levobupivacaine or levobupivacaine
      intra-articularly 10 minutes before medical tourniquet deaerated.

      Postoperative analgesia was maintained with morphine in patient-controlled analgesia.
      Patients postoperative VAS values and analgesic consumptions were recorded in postoperative
      24 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesic consumption</measure>
    <time_frame>up to 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>before deaerate the medical tourniquet, after deaerate the tourniquet, postoperative 0, 30, 60, 90, 120 minutes ,in the PACU, 4, 6, 12, 24, 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>before deaerate the medical tourniquet, after deaerate the tourniquet, postoperative 0, 30, 60, 90, 120 minutes ,in the PACU, 4, 6, 12, 24, 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale-rest</measure>
    <time_frame>postoperative 0, 30, 60, 90, 120 minutes in the PACU, 4, 6, 12, 24, 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale-movement</measure>
    <time_frame>postoperative 0, 30, 60, 90, 120 minutes ,in the PACU, 4, 6, 12, 24, 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraarticular 19 ml 0.5% levobupivacaine and 1 ml 0.9% sodium chloride administered. postoperative morphine administered for analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraarticular 19 ml 0.5% levobupivacaine and 1 ml (100 mcg/ml) dexmedetomidine administered, postoperative morphine used for analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>intraarticular</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <other_name>chirocaine 0.5%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>intraarticular 1 ml (100 mcg)</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>precedex, 100mcg/ml</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>intravenously, patient-controlled analgesia</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>morphine HCL, 10 mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older than 18 yo

          -  scheduled for arthroscopic knee surgery

        Exclusion Criteria:

          -  younger than 18 yo

          -  known allergy relevant drugs

          -  contraindication for general anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Resul Altuntas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TC Erciyes University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ayse Ulgey, Ast Prof</last_name>
    <role>Study Director</role>
    <affiliation>TC Erciyes University</affiliation>
  </overall_official>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2013</study_first_submitted>
  <study_first_submitted_qc>August 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 7, 2013</last_update_submitted>
  <last_update_submitted_qc>August 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Ayse Ulgey</investigator_full_name>
    <investigator_title>Assisstant Professor</investigator_title>
  </responsible_party>
  <keyword>Arthroscopic knee surgery</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

